Showing results (551-560 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|January 1, 1990
Stroke in Asia: an epidemiological considerationA ViriyavejakulClinical Neuropharmacology|January 1, 1990
Diagnosis and assessment of age-associated memory impairmentT H Crook, G J Larrabee, J R YoungjohnClinical Neuropharmacology|February 9, 2011
Intravenous immunoglobulins are a therapeutic option in the treatment of multiple sclerosis relapseIrina Elovaara, Hanna Kuusisto, Xingchen Wu, et al.Clinical Neuropharmacology|March 18, 2011
The emergence of devastating impulse control disorders during dopamine agonist therapy of the restless legs syndromeDien Dang, David Cunnington, John SwiecaClinical Neuropharmacology|January 1, 1985
Bromocriptine: problems with low-dose de novo therapy in Parkinson's diseaseJ D Grimes, M R DelgadoClinical Neuropharmacology|March 4, 2021
Activation Syndrome in a Patient With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine: A Case ReportSümeyra Elif Kaplan Karakaya, Çiğdem Yektaş, Ali Evren TufanClinical Neuropharmacology|July 31, 2019
Role of Pregabalin in Treatment of Polyneuropathy in Multiple Myeloma Patients: A Retrospective StudyMarta Maschio, Andrea Mengarelli, Alessia Zarabla, et al.Clinical Neuropharmacology|October 1, 1989
A study of the cardiopressor effects of lisuride in the treatment of parkinsonism and pathological aging brainG Micieli, E Martignoni, G Bono, et al.Clinical Neuropharmacology|May 26, 2016
Exploratory Phase II Trial to Evaluate the Safety and the Antiepileptic Effect of Pitolisant (BF2.649) in Refractory Partial Seizures, Given as Adjunctive Treatment During 3 MonthsPierre Collart Dutilleul, Philippe Ryvlin, Philippe Kahane, et al.Clinical Neuropharmacology|November 9, 2013
Atypical antipsychotics in the treatment of posttraumatic stress disorderHee Ryung Wang, Young Sup Woo, Won-Myong BahkPageof 236